Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 27, 2017, to report its financial results for the second quarter ended June 30, 2017. The key information is contained within the press release furnished as Exhibit 99.1, which details the company's performance during the period. Investors should refer to this press release for specific financial metrics, revenue figures, profitability, and any forward-looking statements or guidance provided by the company. The filing itself serves as the official notification of the release of this financial information.
Key Highlights
- 1Boston Scientific announced its second quarter 2017 financial results via a press release on July 27, 2017.
- 2The 8-K filing incorporates the press release by reference, making it the primary source of Q2 2017 financial details.
- 3This filing pertains to Item 2.02 (Results of Operations and Financial Condition).
- 4The information provided is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- 5Exhibit 99.1 contains the full press release detailing financial performance for the quarter ended June 30, 2017.